Clin2
NCT07247370Possibly a fitNot yet recruiting

Ketamine therapy for alcohol use and depression

Alcohol Use Disorder (AUD)Major Depressive Disorder (MDD)Comorbidities and Coexisting Conditions

Treatments studied

Part of Mental health clinical trials.

This study tests if ketamine-assisted therapy can help people who struggle with both alcohol use disorder and depression. You'll receive ketamine alongside psychological support to see if it reduces drinking and improves mood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
20 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You must have moderate to severe alcohol use disorder and current major depression.
  • You should be motivated to cut down or stop drinking alcohol.
  • You must drink at least 21 standard drinks per week (or have heavy drinking days several times a week).
  • You must be between 18 and 70 years old.
  • You need stable housing and the ability to attend all study visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06969937Recruiting· Phase 2
Ketamine and Neurofeedback for Alcohol Use Disorder

This study tests whether combining ketamine with a brain-training technique called neurofeedback can help people reduce or stop drinking alcohol. It may offer a new treatment option for alcohol use disorder.

Zurich
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT06891300Recruiting· Phase 2/Phase 3
Ketamine for Suicidal Thoughts in Depression

This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.

Ottawa, Ontario
NCT07139106Not yet recruiting· Phase 4
Ketamine and brain opioid receptors for suicidal thoughts

This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.

New York, New York
NCT07569198Recruiting· Phase 2
Ketamine plus therapy for depression with suicidal thoughts

This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.

Toronto, Ontario
NCT06620276Recruiting
Ketamine and therapy for alcohol use disorder and depression

This trial tests if combining ketamine infusions with weekly therapy can help people who have both alcohol use disorder and hard-to-treat depression. You may qualify if you drink at least moderately, have treatment-resistant depression, and are willing to attend 8 therapy sessions.

Montreal, Quebec

Hear when a new Comorbidities and Coexisting Conditions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.